New drug aims to shrink Hard-to-Treat lung cancers
NCT ID NCT05882058
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 4 times
Summary
This phase 2 trial tests BI 764532 (obrixtamig), an antibody-like drug designed to help the immune system attack cancer cells. It is for adults with advanced small cell lung cancer or other neuroendocrine cancers that have not responded to prior treatments. The study compares two doses to find one that is tolerable and effective, with the goal of shrinking tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BI 764532 (obrixtamig), an antibody-like molecule that helps the immune system fight cancer
- What this could lead to
- If it works, this could point toward a new treatment option for people with advanced small cell lung cancer or other neuroendocrine cancers that have stopped responding to standard therapy.
- What could go wrong
- This is a mid-stage trial with only 204 participants, so results may not apply to everyone. The drug may cause side effects or fail to shrink tumors in many patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
960 Hospital of the Chinese People's Liberation Army
RECRUITINGJinan, 250031, China
-
Aichi Cancer Center Hospital
RECRUITINGAichi, Nagoya, 464-8681, Japan
-
Asan Medical Center
COMPLETEDSeoul, 05505, South Korea
-
Asklepios Fachkliniken München-Gauting
COMPLETEDGauting, 82131, Germany
-
Chang Gung Memorial Hospital, Linkou
COMPLETEDTaoyuan County, 333, Taiwan
-
Dana-Farber Cancer Institute
COMPLETEDBoston, Massachusetts, 02215, United States
-
Evangelische Lungenklinik Berlin
COMPLETEDBerlin, 13125, Germany
-
Freeman Hospital
RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
-
H. Lee Moffitt Cancer Center and Research Institute
RECRUITINGTampa, Florida, 33612, United States
-
HOP Civil
COMPLETEDStrasbourg, 67091, France
-
HOP Intercommunal
COMPLETEDCréteil, 94000, France
-
Hospital CUF Descobertas-Lisboa-69316
COMPLETEDLisbon, 1350-352, Portugal
-
Hospital CUF Porto
COMPLETEDPorto, 4100-180, Portugal
-
Hospital Clinico Universitario de Valencia
COMPLETEDValencia, 46010, Spain
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Virgen de la Victoria
RECRUITINGMálaga, 29010, Spain
-
Hospital del Mar
COMPLETEDBarcelona, 08003, Spain
-
Hôpital Cochin
COMPLETEDParis, 75014, France
-
Indiana University
COMPLETEDIndianapolis, Indiana, 46202, United States
-
Infirmary Cancer Care
RECRUITINGMobile, Alabama, 36607, United States
-
Japanese Foundation for Cancer Research
RECRUITINGTokyo, Koto-ku, 135-8550, Japan
-
Kindai University Hospital
RECRUITINGOsaka, Sakai, 590-0197, Japan
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
COMPLETEDNew York, New York, 10016, United States
-
Leicester Royal Infirmary
RECRUITINGLeicester, LE1 5WW, United Kingdom
-
LungenClinic Grosshansdorf GmbH
ACTIVE_NOT_RECRUITINGGroßhansdorf, 22927, Germany
-
MHAT Heart and brain
COMPLETEDPleven, 5804, Bulgaria
-
Mayo Clinic Cancer Center
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic, Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic-Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10461, United States
-
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd.
COMPLETEDPanagyurishte, 4500, Bulgaria
-
NCKUH
COMPLETEDTainan, 704, Taiwan
-
National Cancer Center Hospital
RECRUITINGTokyo, Chuo-ku, 104-0045, Japan
-
National Cancer Center Hospital East
RECRUITINGChiba, Kashiwa, 277-8577, Japan
-
Osaka International Cancer Institute
RECRUITINGOsaka, Osaka, 541-8567, Japan
-
Qilu Hospital, Shangdong University
RECRUITINGJinan, 250012, China
-
Samsung Medical Center
ACTIVE_NOT_RECRUITINGSeoul, 06351, South Korea
-
Sendai Kousei Hospital
COMPLETEDMiyagi, Sendai, 981-0914, Japan
-
Severance Hospital
RECRUITINGSeoul, 03722, South Korea
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
-
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine
RECRUITINGHangzhou, 310016, China
-
Taipei Veterans General Hospital
COMPLETEDTaipei, 11217, Taiwan
-
The Christie Hospital
RECRUITINGManchester, M20 4BX, United Kingdom
-
The Second Affiliated Hospital to Nanchang University
RECRUITINGNanchang, 330006, China
-
UZ Leuven
RECRUITINGLeuven, 3000, Belgium
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, 9000, Belgium
-
University College Hospital
RECRUITINGLondon, WC1E 6AG, United Kingdom
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94143, United States
-
University of Kansas Cancer Center
COMPLETEDWestwood, Kansas, 66205, United States
-
University of Kentucky Medical Center
RECRUITINGLexington, Kentucky, 40536, United States
-
University of Maryland School of Medicine
RECRUITINGBaltimore, Maryland, 21201, United States
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
-
Universitätsklinikum Carl Gustav Carus Dresden
RECRUITINGDresden, 01307, Germany
-
Universitätsklinikum Erlangen
RECRUITINGErlangen, 91054, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
RECRUITINGMainz, 55131, Germany
-
Valkyrie Clinical Trials
RECRUITINGLos Angeles, California, 90067, United States
-
Virginia Commonwealth University Health- Adult Outpatient Pavilion
RECRUITINGRichmond, Virginia, 23219, United States
-
West China Hospital, Sichuan University
RECRUITINGChengdu, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Immunotherapy combo targets rare, aggressive lung cancer
- Can head radiation stop lung cancer from spreading to the brain?
- New hope for tough lung cancer: drug plus radiation combo shows promise in early trial
- New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
- New hope for tough lung cancer: early trial launches in china